{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:53:38Z","timestamp":1794585218101,"version":"4.9.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-60726-0","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T05:04:16Z","timestamp":1751432656000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Induction of lung mucosal immunity by a next-generation inhaled aerosol COVID-19 vaccine: an open-label, multi-arm phase 1 clinical trial"],"prefix":"10.1038","volume":"16","author":[{"given":"Mangalakumari","family":"Jeyanathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Afkhami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"D\u2019Agostino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Satia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik K.","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Miyasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jann C.","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Zganiacz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen J.","family":"Howie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn","family":"Swinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Aguirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natallia","family":"Kazhdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dvorkin-Gheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Mbuagbaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Fe C.","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nermin","family":"Diab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danica L.","family":"Brister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail M.","family":"Gauvreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4514-1037","authenticated-orcid":false,"given":"Brian D.","family":"Lichty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3426-5069","authenticated-orcid":false,"given":"Matthew S.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1305-6260","authenticated-orcid":false,"given":"Fiona","family":"Smaill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7856-0663","authenticated-orcid":false,"given":"Zhou","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"60726_CR1","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra2206573","volume":"387","author":"DH Barouch","year":"2022","unstructured":"Barouch, D. H. Covid-19 vaccines - immunity, variants, boosters. N. Engl. J. Med.387, 1011\u20131020 (2022).","journal-title":"N. Engl. J. Med."},{"key":"60726_CR2","doi-asserted-by":"crossref","first-page":"101334","DOI":"10.1016\/j.coviro.2023.101334","volume":"61","author":"S Afkhami","year":"2023","unstructured":"Afkhami, S., Kang, A., Jeyanathan, V., Xing, Z. & Jeyanathan, M. Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19. Curr. Opin. Virol. 61, 101334 (2023).","journal-title":"Curr. Opin. Virol."},{"key":"60726_CR3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/jama.2022.22759","volume":"329","author":"PW Marks","year":"2023","unstructured":"Marks, P. W., Gruppuso, P. A. & Adashi, E. Y. Urgent need for next-generation COVID-19 vaccines. JAMA 329, 19\u201320 (2023).","journal-title":"JAMA"},{"key":"60726_CR4","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41577-020-00434-6","volume":"20","author":"M Jeyanathan","year":"2020","unstructured":"Jeyanathan, M. et al. Immunological considerations for COVID-19 vaccine strategies. Nat. Rev. Immunol. 20, 615\u2013632 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"60726_CR5","first-page":"162","volume":"21","author":"AM Carabelli","year":"2023","unstructured":"Carabelli, A. M. et al. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat. Rev. Microbiol. 21, 162\u2013177 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"60726_CR6","first-page":"e068632","volume":"376","author":"ARYB Lee","year":"2022","unstructured":"Lee, A. R. Y. B. et al. Efficacy of Covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis. BMJ 376, e068632 (2022).","journal-title":"BMJ"},{"key":"60726_CR7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41577-022-00815-z","volume":"23","author":"FR Carbone","year":"2023","unstructured":"Carbone, F. R. Unique properties of tissue-resident memory T cells in the lungs: implications for COVID-19 and other respiratory diseases. Nat. Rev. Immunol. 23, 329\u2013335 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"60726_CR8","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-023-00654-6","volume":"8","author":"JM Knisely","year":"2023","unstructured":"Knisely, J. M. et al. Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities\u2014workshop report. NPJ Vaccines 8, 53 (2023).","journal-title":"NPJ Vaccines"},{"key":"60726_CR9","doi-asserted-by":"crossref","first-page":"104585","DOI":"10.1016\/j.ebiom.2023.104585","volume":"92","author":"D Pilapitiya","year":"2023","unstructured":"Pilapitiya, D., Wheatley, A. K. & Tan, H.-X. Mucosal vaccines for SARS-CoV-2: triumph of hope over experience. EBioMedicine 92, 104585 (2023).","journal-title":"EBioMedicine"},{"key":"60726_CR10","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-42433-w","volume":"14","author":"E Mitsi","year":"2023","unstructured":"Mitsi, E. et al. Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination. Nat. Commun. 14, 6815 (2023).","journal-title":"Nat. Commun."},{"key":"60726_CR11","doi-asserted-by":"crossref","first-page":"eadd4853","DOI":"10.1126\/sciimmunol.add4853","volume":"7","author":"J Tang","year":"2022","unstructured":"Tang, J. et al. Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination. Sci. Immunol. 7, eadd4853 (2022).","journal-title":"Sci. Immunol."},{"key":"60726_CR12","volume":"13","author":"TD Hughes","year":"2023","unstructured":"Hughes, T. D. et al. The effect of SARS-CoV-2 variant on respiratory features and mortality. Sci. Rep. 13, 4503 (2023).","journal-title":"Sci. Rep."},{"key":"60726_CR13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3390\/v15010167","volume":"15","author":"S Chatterjee","year":"2023","unstructured":"Chatterjee, S., Bhattacharya, M., Nag, S., Dhama, K. & Chakraborty, C. A Detailed Overview of SARS-CoV-2 Omicron: its sub-variants, mutations and pathophysiology, clinical characteristics, immunological landscape, immune escape, and therapies. Viruses 15, 167 (2023).","journal-title":"Viruses"},{"key":"60726_CR14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","volume":"23","author":"P Moss","year":"2022","unstructured":"Moss, P. The T cell immune response against SARS-CoV-2. Nat. Immunol. 23, 186\u2013193 (2022).","journal-title":"Nat. Immunol."},{"key":"60726_CR15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1146\/annurev-immunol-101721-061120","volume":"41","author":"A Sette","year":"2023","unstructured":"Sette, A., Sidney, J. & Crotty, S. T cell responses to SARS-CoV-2. Annu. Rev. Immunol. 41, 343\u2013373 (2023).","journal-title":"Annu. Rev. Immunol."},{"key":"60726_CR16","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/s41590-023-01621-y","volume":"24","author":"E Antoun","year":"2023","unstructured":"Antoun, E., Peng, Y. & Dong, T. Vaccine-induced CD8\u2009+\u2009T cells are key to protection from SARS-CoV-2. Nat. Immunol. 24, 1594\u20131596 (2023).","journal-title":"Nat. Immunol."},{"key":"60726_CR17","doi-asserted-by":"crossref","first-page":"eadh4529","DOI":"10.1126\/scitranslmed.adh4529","volume":"15","author":"R Zonozi","year":"2023","unstructured":"Zonozi, R. et al. T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19. Sci. Transl. Med. 15, eadh4529 (2023).","journal-title":"Sci. Transl. Med."},{"key":"60726_CR18","doi-asserted-by":"crossref","first-page":"eadj9285","DOI":"10.1126\/sciimmunol.adj9285","volume":"9","author":"HR Wagstaffe","year":"2024","unstructured":"Wagstaffe, H. R. et al. Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults. Sci. Immunol. 9, eadj9285 (2024).","journal-title":"Sci. Immunol."},{"key":"60726_CR19","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2022.01.015","volume":"185","author":"A Tarke","year":"2022","unstructured":"Tarke, A. et al. SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron. Cell 185, 847\u2013859.e11 (2022).","journal-title":"Cell"},{"key":"60726_CR20","doi-asserted-by":"crossref","first-page":"111995","DOI":"10.1016\/j.celrep.2023.111995","volume":"42","author":"S Meyer","year":"2023","unstructured":"Meyer, S. et al. Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants. Cell Rep. 42, 111995 (2023).","journal-title":"Cell Rep."},{"key":"60726_CR21","doi-asserted-by":"crossref","first-page":"1146196","DOI":"10.3389\/fimmu.2023.1146196","volume":"14","author":"G Yang","year":"2023","unstructured":"Yang, G. et al. SARS-CoV-2 epitope-specific T cells: immunity response feature, TCR repertoire characteristics and cross-reactivity. Front. Immunol. 14, 1146196 (2023).","journal-title":"Front. Immunol."},{"key":"60726_CR22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.chom.2023.12.010","volume":"32","author":"TR M\u00fcller","year":"2024","unstructured":"M\u00fcller, T. R. et al. Memory T cells effectively recognize the SARS-CoV-2 hypermutated BA.2.86 variant. Cell Host Microbe 32, 156\u2013161.e3 (2024).","journal-title":"Cell Host Microbe"},{"key":"60726_CR23","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.cell.2022.02.005","volume":"185","author":"S Afkhami","year":"2022","unstructured":"Afkhami, S. et al. Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2. Cell 185, 896\u2013915.e19 (2022).","journal-title":"Cell"},{"key":"60726_CR24","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.cell.2018.09.042","volume":"175","author":"Y Yao","year":"2018","unstructured":"Yao, Y., et al. Induction of autonomous memory alveolar macrophages requires T cell help and is critical to trained immunity. Cell 175, 1634\u20131650.e17 (2018).","journal-title":"Cell"},{"key":"60726_CR25","doi-asserted-by":"crossref","first-page":"e155655","DOI":"10.1172\/jci.insight.155655","volume":"7","author":"M Jeyanathan","year":"2022","unstructured":"Jeyanathan, M., et al. Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humans. JCI Insight 7, e155655 (2022).","journal-title":"JCI Insight"},{"key":"60726_CR26","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.chom.2023.05.004","volume":"31","author":"MG Netea","year":"2023","unstructured":"Netea, M. G. et al. The role of trained immunity in COVID-19: lessons for the next pandemic. Cell Host Microbe 31, 890\u2013901 (2023).","journal-title":"Cell Host Microbe"},{"key":"60726_CR27","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/d41586-023-03557-7","volume":"624","author":"Z Xing","year":"2023","unstructured":"Xing, Z. & Jeyanathan, M. A next-generation inhalable dry powder COVID vaccine. Nature 624, 532\u2013534 (2023).","journal-title":"Nature"},{"key":"60726_CR28","doi-asserted-by":"crossref","first-page":"1151809","DOI":"10.3389\/fimmu.2023.1151809","volume":"14","author":"V Jeyanathan","year":"2023","unstructured":"Jeyanathan, V. et al. Corrigendum: differential biodistribution of adenoviral-vectored vaccine following intranasal and endotracheal deliveries leads to different immune outcomes. Front. Immunol. 14, 1151809 (2023).","journal-title":"Front. Immunol."},{"key":"60726_CR29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41586-023-06951-3","volume":"626","author":"K McMahan","year":"2024","unstructured":"McMahan, K. et al. Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques. Nature 626, 385\u2013391 (2024).","journal-title":"Nature"},{"key":"60726_CR30","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3390\/vaccines11091427","volume":"11","author":"S Wang","year":"2023","unstructured":"Wang, S., et al. Aerosol inhalation of chimpanzee adenovirus vectors (ChAd68) expressing ancestral or omicron BA.1 stabilized pre-fusion spike glycoproteins protects non-human primates against SARS-CoV-2 infection. Vaccines (Basel) 11, 1427 (2023).","journal-title":"Vaccines (Basel)"},{"key":"60726_CR31","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41586-023-06809-8","volume":"624","author":"T Ye","year":"2023","unstructured":"Ye, T. et al. Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization. Nature 624, 630\u2013638 (2023).","journal-title":"Nature"},{"key":"60726_CR32","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1473-3099(14)70845-X","volume":"14","author":"I Satti","year":"2014","unstructured":"Satti, I. et al. Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial. Lancet Infect. Dis. 14, 939\u2013946 (2014).","journal-title":"Lancet Infect. Dis."},{"key":"60726_CR33","volume":"16","author":"S Jia","year":"2025","unstructured":"Jia, S. et al. Effectiveness of a booster dose of aerosolized or intramuscular adenovirus type 5 vectored COVID-19 vaccine in adults: a multicenter, partially randomized, platform trial in China. Nat. Commun. 16, 2969 (2025).","journal-title":"Nat. Commun."},{"key":"60726_CR34","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.4049\/jimmunol.1101122","volume":"187","author":"CL Day","year":"2011","unstructured":"Day, C. L. et al. Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load. J. Immunol. 187, 2222\u20132232 (2011).","journal-title":"J. Immunol."},{"key":"60726_CR35","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1165\/rcmb.2010-0241OC","volume":"45","author":"JR Walrath","year":"2011","unstructured":"Walrath, J. R. & Silver, R. F. The \u03b14\u03b21 integrin in localization of Mycobacterium tuberculosis-specific T helper type 1 cells to the human lung. Am. J. Respir. Cell Mol. Biol. 45, 24\u201330 (2011).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"60726_CR36","doi-asserted-by":"crossref","first-page":"eabp9770","DOI":"10.1126\/sciadv.abp9770","volume":"8","author":"AD L\u00f3pez-Mu\u00f1oz","year":"2022","unstructured":"L\u00f3pez-Mu\u00f1oz, A. D., Kosik, I., Holly, J. & Yewdell, J. W. Cell surface SARS-CoV-2 nucleocapsid protein modulates innate and adaptive immunity. Sci. Adv. 8, eabp9770 (2022).","journal-title":"Sci. Adv."},{"key":"60726_CR37","doi-asserted-by":"crossref","first-page":"107634","DOI":"10.1016\/j.celrep.2020.107634","volume":"31","author":"SJCFM Moorlag","year":"2020","unstructured":"Moorlag, S. J. C. F. M. et al. \u03b2-Glucan induces protective trained immunity against mycobacterium tuberculosis infection: a key role for IL-1. Cell Rep. 31, 107634 (2020).","journal-title":"Cell Rep."},{"key":"60726_CR38","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","volume":"109","author":"J Kleinnijenhuis","year":"2012","unstructured":"Kleinnijenhuis, J. et al. Bacille Calmette-Gu\u00e9rin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc. Natl. Acad. Sci. USA 109, 17537\u201317542 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"60726_CR39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cell.2017.11.025","volume":"172","author":"S Bekkering","year":"2018","unstructured":"Bekkering, S. et al. Metabolic induction of trained immunity through the mevalonate pathway. Cell 172, 135\u2013146.e9 (2018).","journal-title":"Cell"},{"key":"60726_CR40","doi-asserted-by":"crossref","first-page":"e83257","DOI":"10.1371\/journal.pone.0083257","volume":"8","author":"K Sebastian","year":"2013","unstructured":"Sebastian, K. et al. Characterization of SLCO5A1\/OATP5A1, a solute carrier transport protein with non-classical function. PLoS ONE 8, e83257 (2013).","journal-title":"PLoS ONE"},{"key":"60726_CR41","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/jcsm.13022","volume":"13","author":"E Smeets","year":"2022","unstructured":"Smeets, E. et al. A disease-associated missense mutation in CYP4F3 affects the metabolism of leukotriene B4 via disruption of electron transfer. J. Cachexia Sarcopenia Muscle 13, 2242\u20132253 (2022).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"60726_CR42","doi-asserted-by":"crossref","first-page":"672441","DOI":"10.3389\/fimmu.2021.672441","volume":"12","author":"SM Kanth","year":"2021","unstructured":"Kanth, S. M., Gairhe, S. & Torabi-Parizi, P. The role of semaphorins and their receptors in innate immune responses and clinical diseases of acute inflammation. Front. Immunol. 12, 672441 (2021).","journal-title":"Front. Immunol."},{"key":"60726_CR43","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71810-4","volume":"10","author":"S L\u00f3pez-L\u00f3pez","year":"2020","unstructured":"L\u00f3pez-L\u00f3pez, S. et al. NOTCH3 signaling is essential for NF-\u03baB activation in TLR-activated macrophages. Sci. Rep. 10, 14839 (2020).","journal-title":"Sci. Rep."},{"key":"60726_CR44","volume":"4","author":"SM Jung","year":"2013","unstructured":"Jung, S. M. et al. Smad6 inhibits non-canonical TGF-\u03b21 signalling by recruiting the deubiquitinase A20 to TRAF6. Nat. Commun. 4, 2562 (2013).","journal-title":"Nat. Commun."},{"key":"60726_CR45","doi-asserted-by":"crossref","first-page":"e2102698118","DOI":"10.1073\/pnas.2102698118","volume":"118","author":"E Jentho","year":"2021","unstructured":"Jentho, E., et al. Trained innate immunity, long-lasting epigenetic modulation, and skewed myelopoiesis by heme. Proc. Natl. Acad. Sci. USA 118, e2102698118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"60726_CR46","doi-asserted-by":"crossref","first-page":"957107","DOI":"10.3389\/fimmu.2022.957107","volume":"13","author":"MW Russell","year":"2022","unstructured":"Russell, M. W. & Mestecky, J. Mucosal immunity: the missing link in comprehending SARS-CoV-2 infection and transmission. Front. Immunol. 13, 957107 (2022).","journal-title":"Front. Immunol."},{"key":"60726_CR47","doi-asserted-by":"crossref","first-page":"eabq1841","DOI":"10.1126\/science.abq1841","volume":"377","author":"CJ Reynolds","year":"2022","unstructured":"Reynolds, C. J. et al. Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure. Science 377, eabq1841 (2022).","journal-title":"Science"},{"key":"60726_CR48","doi-asserted-by":"crossref","first-page":"101408","DOI":"10.1016\/j.coviro.2024.101408","volume":"66","author":"E Stylianou","year":"2024","unstructured":"Stylianou, E. & Satti, I. Inhaled aerosol viral-vectored vaccines against tuberculosis. Curr. Opin. Virol. 66, 101408 (2024).","journal-title":"Curr. Opin. Virol."},{"key":"60726_CR49","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-023-00717-8","volume":"8","author":"C Singh","year":"2023","unstructured":"Singh, C. et al. Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin\u00ae). NPJ Vaccines 8, 125 (2023).","journal-title":"NPJ Vaccines"},{"key":"60726_CR50","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S1473-3099(23)00350-X","volume":"23","author":"J-X Li","year":"2023","unstructured":"Li, J.-X. et al. Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial. Lancet Infect. Dis. 23, 1143\u20131152 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"60726_CR51","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S1473-3099(21)00396-0","volume":"21","author":"S Wu","year":"2021","unstructured":"Wu, S. et al. Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial. Lancet Infect. Dis. 21, 1654\u20131664 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"60726_CR52","doi-asserted-by":"crossref","first-page":"101583","DOI":"10.1016\/j.xcrm.2024.101583","volume":"6","author":"A Tarke","year":"2024","unstructured":"Tarke, A. et al. SARS-CoV-2 breakthrough infections enhance T cell response magnitude, breadth, and epitope repertoire. Cell Rep. Med. 6, 101583 (2024).","journal-title":"Cell Rep. Med."},{"key":"60726_CR53","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41586-023-06937-1","volume":"626","author":"I Uddb\u00e4ck","year":"2024","unstructured":"Uddb\u00e4ck, I. et al. Prevention of respiratory virus transmission by resident memory CD8\u2009+\u2009T cells. Nature 626, 392\u2013400 (2024).","journal-title":"Nature"},{"key":"60726_CR54","doi-asserted-by":"crossref","first-page":"102278","DOI":"10.1016\/j.coi.2022.102278","volume":"80","author":"J Tang","year":"2023","unstructured":"Tang, J. & Sun, J. Lung tissue-resident memory T cells: the gatekeeper to respiratory viral (re)-infection. Curr. Opin. Immunol. 80, 102278 (2023).","journal-title":"Curr. Opin. Immunol."},{"key":"60726_CR55","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/s41590-022-01354-4","volume":"23","author":"M Jeyanathan","year":"2022","unstructured":"Jeyanathan, M. et al. Parenteral BCG vaccine induces lung-resident memory macrophages and trained immunity via the gut-lung axis. Nat. Immunol. 23, 1687\u20131702 (2022).","journal-title":"Nat. Immunol."},{"key":"60726_CR56","doi-asserted-by":"crossref","first-page":"e171742","DOI":"10.1172\/JCI171742","volume":"133","author":"NE Stevens","year":"2023","unstructured":"Stevens, N. E., et al. No evidence of durable trained immunity after two doses of adenovirus-vectored or mRNA COVID-19 vaccines. J. Clin. Invest. 133, e171742 (2023).","journal-title":"J. Clin. Invest."},{"key":"60726_CR57","doi-asserted-by":"crossref","first-page":"e162581","DOI":"10.1172\/JCI162581","volume":"133","author":"DM Murphy","year":"2023","unstructured":"Murphy, D. M., et al. Trained immunity is induced in humans after immunization with an adenoviral vector COVID-19 vaccine. J. Clin. Invest. 133, e162581 (2023).","journal-title":"J. Clin. Invest."},{"key":"60726_CR58","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.3390\/jcm12031154","volume":"12","author":"J Wen","year":"2023","unstructured":"Wen, J., Liu, Q., Tang, D. & He, J.-Q. Efficacy of BCG vaccination against COVID-19: systematic review and meta-analysis of randomized controlled trials. J. Clin. Med. 12, 1154 (2023).","journal-title":"J. Clin. Med."},{"key":"60726_CR59","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41564-023-01359-1","volume":"8","author":"SR Mackin","year":"2023","unstructured":"Mackin, S. R. et al. Fc-\u03b3R-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2. Nat. Microbiol.8, 569\u2013580 (2023).","journal-title":"Nat. Microbiol."},{"key":"60726_CR60","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-021-04017-w","volume":"599","author":"R Yamin","year":"2021","unstructured":"Yamin, R. et al. Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy. Nature 599, 465\u2013470 (2021).","journal-title":"Nature"},{"key":"60726_CR61","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41577-022-00813-1","volume":"23","author":"A Zhang","year":"2023","unstructured":"Zhang, A. et al. Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection. Nat. Rev. Immunol. 23, 381\u2013396 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"60726_CR62","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/infdis\/jiac142","volume":"226","author":"M Le Gars","year":"2022","unstructured":"Le Gars, M. et al. Impact of preexisting anti-adenovirus 26 humoral immunity on immunogenicity of the Ad26.COV2.S coronavirus disease 2019 vaccine. J. Infect. Dis. 226, 979\u2013982 (2022).","journal-title":"J. Infect. Dis."},{"key":"60726_CR63","doi-asserted-by":"crossref","first-page":"205ra134","DOI":"10.1126\/scitranslmed.3006843","volume":"5","author":"F Smaill","year":"2013","unstructured":"Smaill, F. et al. A human type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity. Sci. Transl. Med. 5, 205ra134\u2013205ra134 (2013).","journal-title":"Sci. Transl. Med."},{"key":"60726_CR64","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/infdis\/jiw467","volume":"214","author":"M Jeyanathan","year":"2016","unstructured":"Jeyanathan, M. et al. Induction of an immune-protective T-cell repertoire with diverse genetic coverage by a novel viral-vectored tuberculosis vaccine in humans. J. Infect. Dis. 214, 1996\u20132005 (2016).","journal-title":"J. Infect. Dis."},{"key":"60726_CR65","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.immuni.2021.08.001","volume":"54","author":"MM Painter","year":"2021","unstructured":"Painter, M. M. et al. Rapid induction of antigen-specific CD4\u2009+\u2009T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination. Immunity 54, 2133\u20132142.e3 (2021).","journal-title":"Immunity"},{"key":"60726_CR66","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","volume":"26","author":"F Amanat","year":"2020","unstructured":"Amanat, F. et al. A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat. Med. 26, 1033\u20131036 (2020).","journal-title":"Nat. Med."},{"key":"60726_CR67","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41586-020-2912-6","volume":"590","author":"D Stadlbauer","year":"2021","unstructured":"Stadlbauer, D. et al. Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City. Nature 590, 146\u2013150 (2021).","journal-title":"Nature"},{"key":"60726_CR68","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha, V. K. et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267\u2013273 (2003).","journal-title":"Nat. Genet."},{"key":"60726_CR69","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jclinepi.2014.03.012","volume":"67","author":"ME Glickman","year":"2014","unstructured":"Glickman, M. E., Rao, S. R. & Schultz, M. R. False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies. J. Clin. Epidemiol. 67, 850\u2013857 (2014).","journal-title":"J. Clin. Epidemiol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60726-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60726-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60726-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T05:04:32Z","timestamp":1751432672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60726-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["60726"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-60726-0","relation":{"has-review":[{"id-type":"doi","id":"10.14293\/S2199-1006.1.SOR-UNCAT.A12223143.v1.RTDJBO","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"28 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.D.L., Z.X., and F.S. are listed as co-inventors on the patent \u201cNovel COVID vaccine and method for delivery\u201d (PCT\/CA2022\/051107, Pub date: Jan 19, 2023 which is currently in the national phase with ID# WO2023283745). M.S.M., B.D.L., Z.X., and F.S. are co-founders of AeroImmune Inc. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6000"}}